OKYO Pharma (OKYO) Other Non-Current Liabilities (2023 - 2025)
OKYO Pharma (OKYO) posted quarterly Other Non-Current Liabilities of $93748.0 for Q3 2025, little changed year-over-year from $93748.0 in Q3 2024, and little changed quarter-over-quarter from $93748.0 in Q1 2025.
OKYO Pharma (OKYO) Other Non-Current Liabilities (2023 - 2025) Analysis & Trends
OKYO Pharma (OKYO) has reported Other Non-Current Liabilities for 3 consecutive years, with $93748.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Other Non-Current Liabilities changed 0.0% year-over-year to $93748.0; the TTM figure through Sep 2025 stood at $93748.0 (changed 0.0% YoY), while the FY2025 annual figure was $93748.0, changed 0.0% from the prior year.
- Other Non-Current Liabilities steadied at $93748.0 in Q3 2025 per OKYO's latest filing, from $93748.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $93748.0 in Q1 2024 and bottomed at $89956.0 in Q3 2023.
- Historically, Other Non-Current Liabilities has averaged $92989.6 across 3 years, with a median of $93748.0 in 2024.
- Annual changes were most pronounced in 2024 — Other Non-Current Liabilities climbed 4.22% — and 2025, when it changed 0.0%.
- OKYO Pharma's Other Non-Current Liabilities stood at $89956.0 in 2023, then rose by 4.22% to $93748.0 in 2024, then changed by 0.0% to $93748.0 in 2025.
- Business Quant data shows OKYO's Other Non-Current Liabilities at $93748.0 in Q3 2025, $93748.0 in Q1 2025, and $93748.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | OKYO Pharma | 1.52 Bn | 1.52 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 93,748.00 |
| Mar 31, 2025 | 93,748.00 |
| Sep 30, 2024 | 93,748.00 |
| Mar 31, 2024 | 93,748.00 |
| Sep 30, 2023 | 89,956.00 |